跳至主要内容
临床试验/NCT01074424
NCT01074424Unknown不适用

Development of a Serum Proteomic Profile for Cervical Cancer With Potential Prognostic Value

Gynecologic Oncology Group0 个研究点目标入组 84 人开始时间: 2010年2月最近更新:
适应症

试验速览

阶段
不适用
入组人数
84
主要终点
Generation of a serum proteomic profile using banked pre-treatment serum specimens that may have potential utility for cervical cancer prognosis (overall survival and progression-free survival [PFS])

研究概览

简要总结

RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer. It may also help doctors predict how well patients will respond to treatment.

PURPOSE: This research study is looking at biomarkers in blood samples from patients with invasive cervical cancer.

详细描述

OBJECTIVES:

Primary

  • To develop a serum proteomic profile for cervical cancer using banked pre-treatment serum specimens from patients with invasive cervical cancer and to determine if this serum proteomic profile has possible utility in cervical cancer prognosis.

Secondary

  • To develop a serum proteomic profile for cervical cancer using banked post-treatment serum specimens from these patients and to determine if this serum proteomic profile has possible utility in cervical cancer prognosis.

研究设计

研究类型
Observational

入排标准

性别
Female
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Generation of a serum proteomic profile using banked pre-treatment serum specimens that may have potential utility for cervical cancer prognosis (overall survival and progression-free survival [PFS])

次要结局

  • Generation of a serum proteomic profile using banked post-treatment serum specimens that may have potential utility for cervical cancer prognosis (overall survival and PFS)

研究者

申办方类型
Network

相似试验

Studying Biomarkers in Blood Samples From Patients... | 临床试验